FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Cosmos Health Inc. Stock AnalysisComprehensive stock analysis for Cosmos Health Inc. (COSM) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCOSM
COSM
Cosmos Health Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
COSM
Home🔹Stocks🔹Cosmos Health Inc.

Cosmos Health Inc.

🇺🇸COSM•NASDAQ

Cosmos Health Inc.

🇺🇸COSM•NASDAQ
Market cap
$13.80M
Sentiment

Your view on COSM

Mkt Cap
$13.80M
Sentiment
Your view
COSM
Cosmos Health Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
COSM
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cosmos Health Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Grigorios Siokas
Headquarters
141 West Jackson Boulevard, Chicago, IL, US
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Grigorios Siokas
Headquarters
141 West Jackson Boulevard, Chicago, IL, US
Description

Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace.

The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility.

It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Cosmos Health Inc., and the rating behind it. COSM last traded at $0.25; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Cosmos Health Inc.. Starting points for Cosmos Health Inc.: EPS -$0.41, beta 4.17 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Cosmos Health Inc.. Cosmos Health Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Cosmos Health Inc.. Trailing twelve-month EPS for Cosmos Health Inc. stands at -$0.41. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Cosmos Health Inc.. Cosmos Health Inc. has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Cosmos Health Inc. valued side by side against its closest peers. Cosmos Health Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Cosmos Health Inc., and how their positions are changing. At a $13.8M market value, institutional positions materially move Cosmos Health Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Cosmos Health Inc. executives and directors. Shares of Cosmos Health Inc. have traded between $0.28 and $1.32 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Cosmos Health Inc.. Cosmos Health Inc. is a $13.8M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Cosmos Health Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Cosmos Health Inc.. Coverage tracks Cosmos Health Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • FEMY — Femasys Inc.
  • LSTA — Lisata Therapeutics, Inc.
  • MTVA — MetaVia Inc.
  • NCNA — NuCana plc
  • NXGL — NEXGEL, Inc.

More Medical - Pharmaceuticals companies

  • RPGLF — Regent Pacific Group Limited
  • RPRX — Royalty Pharma plc
  • RSCI — Redwood Scientific Technologies, Inc.
  • RTEZ — Rest Ez Inc.
  • RTSL — Rapid Therapeutic Science Laboratories, Inc.
  • RX.V — BioSyent Inc.
  • SBHMY — Sino Biopharmaceutical Limited
  • SBMFF — Sino Biopharmaceutical Limited
  • SCNX — Scienture Holdings, Inc.
  • SCYX — SCYNEXIS, Inc.
  • SDEV — Stablecoin Development Corp.
  • SDGCF — Sundrug Co.,Ltd.

ETFs holding Cosmos Health Inc.

  • VXF — Vanguard Extended Market ETF (0.00%)

News

Latest Market News